Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Aripiprazole

Reversible cerebral vasoconstriction syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Shakeel HA, et al. A Rare Presentation of Reversible Cerebral Vasoconstriction Syndrome (RCVS) Secondary to the Concurrent Use of Cannabis and Aripiprazole. Annals of Neurology 92 (Suppl. 29): S63 abstr. M114, Oct 2022. Available from: URL: http://doi.org/10.1002/ana.26484 [abstract] Shakeel HA, et al. A Rare Presentation of Reversible Cerebral Vasoconstriction Syndrome (RCVS) Secondary to the Concurrent Use of Cannabis and Aripiprazole. Annals of Neurology 92 (Suppl. 29): S63 abstr. M114, Oct 2022. Available from: URL: http://​doi.​org/​10.​1002/​ana.​26484 [abstract]
Metadaten
Titel
Aripiprazole
Reversible cerebral vasoconstriction syndrome: case report
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-32337-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Imiquimod

Case report

Mutiple drugs

Case report

Tacrolimus